Huons Surpasses 100 Billion KRW in Cumulative Sales of Women's Menopause Probiotic 'Menolacto'

Huons 'Eluvi Menolacto Probiotics' [Photo by Huons]

[Asia Economy Reporter Lee Gwan-joo] Huons announced on the 9th that its women's menopause probiotic 'Eluvi Menolacto Probiotics (Menolacto)' has surpassed cumulative sales of 100 billion KRW within three years of its launch.

Menolacto, first launched in 2020, is a women's menopause health functional probiotic containing 'Lactobacillus acidophilus YT1,' the first functional ingredient in Korea for improving women's menopause health.

Since its launch, sales have grown every year, recording 17.5 billion KRW in the first year, followed by 40 billion KRW in 2021, and exceeding 42 billion KRW last year, reaching cumulative sales of 100 billion KRW over three years.

A Huons representative said, "The high consumer preference for 'probiotics' and the fact that it helps alleviate menopause symptoms, a concern for middle-aged and older women, attracted early attention. By delivering relatable and empathetic messages such as 'Don't Endure Menopause,' the product quickly established itself in the market. This year, we plan to focus on emphasizing our position as the number one brand by communicating facts such as being the top in purchase rate and preference."

This content was produced with the assistance of AI translation services.